Our data support this concept because caspase-2-deficient mice fed a Western diet were protected from many aspects of the metabolic syndrome, namely increased adiposity, insulin resistance, dyslipidemia and NAFLD development and progression. This evidence concerns the gene CASP2 and metabolic dysfunction-associated steatotic liver disease.